Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.19 | N/A |
| PEG Ratio (TTM) | -1.03 | N/A |
| P/S Ratio (TTM) | 0.74 | N/A |
| P/B Ratio (TTM) | 1.07 | N/A |
| P/FCF Ratio (TTM) | 9.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 17.93 | N/A |
| Price to 5YR AVG FCF Ratio | 11.15 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.64% | N/A |
| ROE (TTM) | 6.30% | N/A |
| Net Profit Margin (TTM) | 4.38% | N/A |
| ROIC 5YR AVG | 8.11% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 80.69% | 59.79% | 37.51% |
| Revenue | 0.53% | 0.72% | 1.19% |
| Net Income | 129.85% | 59.29% | 35.82% |
| Cash Flow | -6.07% | -11.66% | 16.76% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.66 | N/A |
| Quick Ratio (TTM) | 0.81 | N/A |
| D/E Ratio (TTM) | 0.82 | N/A |
| Interest Coverage (TTM) | 2.66 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.77 | N/A |
| LTL to 5YR AVG FCF | 8.57 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.67% | N/A |